跳至主要内容
临床试验/ITMCTR2022000094
ITMCTR2022000094招募中1 期

Efficacy evaluation and mechanism study of Yiqi Huashi and Jiedu Tongluo methods in chronic liver disease

Guang'anmen Hospital, China Academy of Chinese Medical Sciences0 个研究点开始时间: 待定最近更新:
适应症

试验速览

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 65(—)
性别
Male

入选标准

  • 1. Meet the diagnostic criteria for autoimmune hepatitis;
  • 2. Meet the diagnostic criteria of Ganyu and PiXu;
  • 3. The age is between 18-65 years old, and the gender is not limited;
  • 4. Willing to participate in this research and sign the informed consent.

排除标准

  • 1. Patients with liver damage caused by other reasons (such as viral, drug, alcoholic and non-alcoholic fatty liver disease, etc.);
  • 2. Those with acute severe complications, those with critical illnesses such as liver cirrhosis, decompensated hepatic encephalopathy, and liver failure;
  • 3. Pregnant or lactating women, those with allergic constitution;
  • 4. Patients with mental disorders who cannot cooperate with this study;
  • 5. Patients with severe heart, brain, lung, kidney, hematopoietic, immune and other system diseases;
  • 6. Other conditions deemed inappropriate by the researcher.

研究者

相似试验